Visit the Lablogic Systems web site
Click on the advert above to visit the company web site

Product category: Chromatography software
News Release from: Lablogic Systems | Subject: Debra
Edited by the Laboratorytalk Editorial Team on 09 November 2007

Sanofi-Aventis takes Debra for seven
sites

Sanofi-Aventis has adopted LabLogic's Debra Lims for non-clinical Adme studies across all seven of its R+D locations in Europe and North America - the biggest multi-site application of Debra to date

Sanofi-Aventis is running the latest release of Debra (5.6.3) on a Citrix server in its global metabolism and pharmacokinetic department in Montpellier, with connections to Chilly-Mazarin, Alfortville, Frankfurt, Budapest, and Bridgewater USA It has taken three years to implement the programme, beginning in 2004 with the decision to centralise and the choice of Debra as the Lims best suited to meeting the needs of the different sites

User requirement specifications were drawn up in 2005 for development by LabLogic the following year.

The system was validated in the first half of 2007 in time for implementation in June.

The harmonisation resolves inconsistencies in Lims practices following the Sanofi-Synthelabo/Aventis merger, as a result of which some sites had more experience of Debra than others and two were using different systems entirely.

"We anticipate that standardising on Debra will reduce costs and help us to follow the same studies procedures at all our sites, but the biggest advantage is likely to be the sharing of data," said Valerie Gall of the Montpellier GMPK. Request a free brochure from Lablogic Systems ...

"With all our Adme compound information on a single database we will be able to compare studies from different sites quickly and easily.".

Lablogic Systems: contact details and other news
Email this article to a colleague
Register for the free Laboratorytalk email newsletter
Laboratorytalk Home Page

Search the Pro-Talk network of sites

Visit the Lablogic Systems web site